[{"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q2_USD":6760000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":4675000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":2528000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":293000.0,"DeferredCompensationLiabilityClassifiedNoncurrent_0_Q2_USD":34000.0,"ProceedsFromIssuanceInitialPublicOffering_2_Q2_USD":108078000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":4675000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":2528000.0,"OtherLiabilitiesCurrent_0_Q2_USD":782000.0,"ShortTermInvestments_0_Q2_USD":44351000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":161314000.0,"OtherAssetsCurrent_0_Q2_USD":753000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":14.37,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":128000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":-21000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_2_Q2_USD":1500000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":127000.0,"InvestmentIncomeInterest_2_Q2_USD":816000.0,"InvestmentIncomeInterest_1_Q2_USD":260000.0,"OtherComprehensiveIncomeLossNetOfTax_2_Q2_USD":-21000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":-40000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-33872000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-16531000.0,"StockIssuedDuringPeriodValueNewIssues_2_Q2_USD":6427000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":24208000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":1019.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":9.55,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":-40000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":1000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":44224000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":44351000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":71000.0,"RestrictedCashNoncurrent_0_Q2_USD":500000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_2_Q2_USD":104115000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_2_Q2_USD":70102000.0,"OtherNoncashIncomeExpense_2_Q2_USD":25000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":2377000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":4444000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":782000.0,"OperatingLeaseLiability_0_Q2_USD":5226000.0,"NumberOfOperatingSegments_2_Q2_Segment":1.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":1121000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":571000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":1173000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":1208000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":1244000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q2_USD":1280000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q2_USD":871000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":6347000.0,"InterestReceivableCurrent_0_Q2_USD":116000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_2_Q2_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_2_Q2_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_2_Q2_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_2_Q2_USD":0.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_0_Q2_USD":0.0,"CommonStocksIncludingAdditionalPaidInCapital_0_Q2_USD":330300000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":120488000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q2_USD":205200000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":1628.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q2_USD":15549000.0,"NonoperatingIncomeExpense_2_Q2_USD":860000.0,"NonoperatingIncomeExpense_1_Q2_USD":438000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":31409000.0,"StockholdersEquity_0_Q2_USD":202774000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-127653000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":3635000.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":6427000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":5445000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":72000.0,"NetIncomeLoss_2_Q2_USD":-33851000.0,"NetIncomeLoss_1_Q2_USD":-16491000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-28085000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":33941000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":114632000.0,"LiabilitiesCurrent_0_Q2_USD":9870000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":217122000.0,"Liabilities_0_Q2_USD":14348000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":416000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":8313000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":4322000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-1.21,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.53,"CommonStockSharesOutstanding_0_Q2_shares":32882000.0,"CommonStockSharesIssued_0_Q2_shares":32906000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":160814000.0,"AssetsCurrent_0_Q2_USD":210610000.0,"Assets_0_Q2_USD":217122000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":4013000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":127000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":27948000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q2_USD":407000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"CommonStockSharesAuthorized_0_Q2_shares":200000000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q2_USD":26900000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":97000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":21.58,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":1.52,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":14.13,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":3989.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_2_Q2_USD":20.81,"PropertyPlantAndEquipmentGross_0_Q2_USD":5738000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q2_USD":1560000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":2103000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_2_Q2_USD":127000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":72000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":84.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2_Q2_pure":0.0,"ShareBasedCompensation_2_Q2_USD":4675000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":26469000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":12607000.0,"PreferredStockValue_0_Q2_USD":null,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"OperatingIncomeLoss_2_Q2_USD":-34711000.0,"OperatingIncomeLoss_1_Q2_USD":-16929000.0,"OperatingExpenses_2_Q2_USD":34782000.0,"OperatingExpenses_1_Q2_USD":16929000.0,"DepreciationAndAmortization_2_Q2_USD":479000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_2_Q2_USD":407000.0,"Ticker":"CRNX","CIK":"1658247","name":"CRINETICS PHARMACEUTICALS, INC.","OfficialName":"Crinetics Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1104302360.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200807"}]